Agenesis of the corpus callosum, developmental delay, autism spectrum disorder, facial dysmorphism, and posterior polymorphous corneal dystrophy associated with ZEB1 gene deletion.
Ayeshah ChaudhryBrian Hon-Yin ChungDimitri J StavropoulosMarcela P ArayaAsim AliElise HeonDavid ChitayatPublished in: American journal of medical genetics. Part A (2017)
We report on a girl diagnosed prenatally with agenesis of the corpus callosum (ACC) on fetal ultrasound and MRI. On postnatal follow-up she was noted to have developmental delay, facial dysmorphism, autism spectrum disorder, and posterior polymorphous corneal dystrophy (PPD). Array-comparative genomic hybridization analysis (Array-CGH) showed a 2.05 Mb de novo interstitial deletion at 10p11.23p11.22. The deleted region overlaps 1 OMIM Morbid Map gene, ZEB1 (the zinc finger E-box binding homeobox transcription factor 1), previously associated with posterior polymorphous corneal dystrophy type 3 (PPCD3). To our best knowledge this is the first reported case with a deletion of the ZEB1 gene in an individual with ACC and PPD, showing that the haploinsufficiency of the ZEB1 is likely the cause of our patient's phenotype.
Keyphrases
- autism spectrum disorder
- epithelial mesenchymal transition
- copy number
- transcription factor
- long non coding rna
- genome wide identification
- early onset
- genome wide
- optical coherence tomography
- magnetic resonance imaging
- wound healing
- intellectual disability
- healthcare
- attention deficit hyperactivity disorder
- high resolution
- high throughput
- bariatric surgery
- preterm infants
- case report
- dna methylation
- magnetic resonance
- mass spectrometry
- cataract surgery
- obese patients
- genome wide analysis
- data analysis
- contrast enhanced ultrasound